Benjamin Edwards Inc’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Sell
46,033
-12,168
-21% -$2.62M 0.1% 210
2026
Q1
$11.7M Buy
58,201
+27,721
+91% +$5.73M 0.12% 192
2025
Q4
$6.3M Sell
30,480
-1,131
-4% -$226K 0.07% 264
2025
Q3
$5.67M Buy
31,611
+2,803
+10% +$477K 0.06% 280
2025
Q2
$4.65M Buy
28,808
+8,304
+40% +$1.32M 0.06% 292
2025
Q1
$3.49M Sell
20,504
-2,583
-11% -$449K 0.05% 316
2024
Q4
$3.84M Buy
23,087
+1,886
+9% +$322K 0.06% 303
2024
Q3
$3.65M Buy
21,201
+20,606
+3,463% +$3.41M 0.05% 320
2024
Q2
$92K Hold
595
0.02% 431
2024
Q1
$91K Hold
595
0.02% 423
2023
Q4
$94K Hold
595
0.02% 423
2023
Q3
$87K Hold
595
0.02% 407
2023
Q2
$91K Hold
595
0.02% 397
2023
Q1
$92K Hold
595
0.02% 372
2022
Q4
$92K Hold
595
0.02% 360
2022
Q3
$79K Hold
595
0.02% 370
2022
Q2
$81K Hold
595
0.02% 367
2022
Q1
$89K Hold
595
0.03% 377
2021
Q4
$96K Hold
595
0.03% 351
2021
Q3
$99K Sell
595
-311
-34% -$53.1K 0.06% 237
2021
Q2
$156K Sell
906
-10
-1% -$1.65K 0.11% 182
2021
Q1
$147K Sell
916
-145
-14% -$24.8K 0.11% 178
2020
Q4
$178K Buy
1,061
+18
+2% +$2.92K 0.14% 154
2020
Q3
$164K Buy
1,043
+104
+11% +$17K 0.14% 137
2020
Q2
$158K Buy
939
+87
+10% +$13.7K 0.13% 130
2020
Q1
$112K Buy
852
+257
+43% +$36.6K 0.12% 134
2019
Q4
$88K Buy
595
+565
+1,883% +$77.6K 0.18% 102
2019
Q3
$4K Hold
30
0.01% 266
2019
Q2
$4K Buy
+30
New +$4.14K 0.01% 271

Other funds holding FBT

Benjamin Edwards Inc's FBT Position: Q2 2026 in Review

Benjamin Edwards Inc reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 21% in Q2 2026, selling an estimated $2.62M and leaving 46,033 shares worth $11.4M. The position accounts for 0.1% of the portfolio, ranked #210.

Benjamin Edwards Inc first reported a position in FBT in Q2 2019 and has held it in 29 quarters since. The position peaked at $11.7M in Q1 2026. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Benjamin Edwards Inc held 46,033 shares of First Trust NYSE Arca Biotechnology Index Fund worth $11.4M as of Q2 2026.
  • Benjamin Edwards Inc sold 12,168 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $2.62M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.1% of Benjamin Edwards Inc's portfolio in Q2 2026, its #210 holding.
  • Benjamin Edwards Inc first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2019 and has held it in 29 quarters since.
  • Benjamin Edwards Inc's First Trust NYSE Arca Biotechnology Index Fund position peaked at $11.7M in Q1 2026.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.